TcMAC21 mouse model recapitulates abnormal vascular physiology observed in humans with Down syndrome
Physiological Reports · 2025
DOI: 10.14814/phy2.70384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2025. Verfasst von Xiangyu Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Integrative Physiology, Florida State University, Tallahassee, Florida, USA. Hauptthemen laut MEDLINE: Down Syndrome, Vascular Stiffness, Endothelium, Vascular. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCCIH NIH HHS, National Center for Complementary and Integrative Health.
Abstract (Originalsprache)
People with Down syndrome (DS) have abnormal vascular physiology, demonstrated by low systolic blood pressure (BP) and low aortic stiffness that are accompanied by endothelial dysfunction. The TcMAC21 mouse model of DS has many features observed in people with DS, although vascular physiology has not been studied. At 4 months old, male and female TcMAC21 mice exhibited lower systolic BP and aortic stiffness, as determined by aortic pulse wave velocity, which are accompanied by blunted carotid artery flow‐mediated vasodilation, indicating endothelial dysfunction, compared to euploid (i.e., control) mice. To determine a potential mechanism for blunted flow‐mediated vasodilation, we assessed endothelial glycocalyx properties, which mechanotransduces fluid shear stress to the endothelial cells, stimulating flow‐mediated vasodilation. We observed a lower glycocalyx thickness in the mesenteric microcirculation of TcMAC21 mice. Vascular abnormalities in TcMAC21 mice were accompanied by systemic inflammation. This is the first study to examine vascular physiology in the TcMAC21 mouse model of DS and investigate glycocalyx properties in any model of DS, including humans. Taken together, these findings support the use of the TcMAC21 mouse model to study the vascular physiology in people with DS and may provide translational insight into the role of glycocalyx in vascular abnormalities in DS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nutrition and Integrative Physiology, Florida State University, Tallahassee, Florida, USA.
- Cardiology Division, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
- Vascular Physiology Group, Department of Cell Biology and Physiology, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
- Department of Biological Science, Florida State University, Tallahassee, Florida, USA.
ORCID-Profile: Daniel R Machin
Förderung
- NCCIH NIH HHS
- National Center for Complementary and Integrative Health
Zitieren
APA
Zheng, X., Sabouri, M., Irwin, B. J., Bernardo, J., & Machin, D. R. (2025). TcMAC21 mouse model recapitulates abnormal vascular physiology observed in humans with Down syndrome. Physiological Reports. https://doi.org/10.14814/phy2.70384
Vancouver
Zheng X, Sabouri M, Irwin BJ, Bernardo J, Machin DR. TcMAC21 mouse model recapitulates abnormal vascular physiology observed in humans with Down syndrome. Physiological Reports. 2025. doi:10.14814/phy2.70384
BibTeX
@article{Zheng2025,
author = {Zheng, Xiangyu and Sabouri, Mostafa and Irwin, Bryan J and Bernardo, Joseph and Machin, Daniel R},
title = {TcMAC21 mouse model recapitulates abnormal vascular physiology observed in humans with Down syndrome},
journal = {Physiological Reports},
year = {2025},
doi = {10.14814/phy2.70384}
}
EUVIMED